A Krüger1, L Oberkircher, S Ruchholtz, M Wollny. 1. Klinik für Unfall-, Hand- und Wiederherstellungschirurgie, Universitätsklinikum Gießen-Marburg, Philipps-Universität Marburg, Baldingerstraße, 35043, Gießen-Marburg, Deutschland, akrueger@med.uni-marburg.de.
Abstract
BACKGROUND: The treatment of osteoporotic vertebral fractures by means of kyphoplasty is an accepted and safe procedure. AIM: In Germany the reimbursement for kyphoplasty and vertebroplasty differs greatly. The growing diversity of suppliers and systems makes a comparison possible and necessary. Besides the illustration of kyphoplasty in the German diagnosis-related group (G-DRG) system and the amendments for 2012 we analyzed the procedures and associated costs. METHOD: Using the example of two manufacturers and different system approaches, both of which can be charged as kyphoplasty, we try to point out the importance of selecting exact comparison parameters. In particular material and treatment costs are compared for both methods.
BACKGROUND: The treatment of osteoporotic vertebral fractures by means of kyphoplasty is an accepted and safe procedure. AIM: In Germany the reimbursement for kyphoplasty and vertebroplasty differs greatly. The growing diversity of suppliers and systems makes a comparison possible and necessary. Besides the illustration of kyphoplasty in the German diagnosis-related group (G-DRG) system and the amendments for 2012 we analyzed the procedures and associated costs. METHOD: Using the example of two manufacturers and different system approaches, both of which can be charged as kyphoplasty, we try to point out the importance of selecting exact comparison parameters. In particular material and treatment costs are compared for both methods.
Authors: S Fürderer; M Anders; B Schwindling; M Salick; C Düber; K Wenda; R Urban; M Glück; P Eysel Journal: Orthopade Date: 2002-04 Impact factor: 1.087
Authors: Douglas Wardlaw; Steven R Cummings; Jan Van Meirhaeghe; Leonard Bastian; John B Tillman; Jonas Ranstam; Richard Eastell; Peter Shabe; Karen Talmadge; Steven Boonen Journal: Lancet Date: 2009-02-24 Impact factor: 79.321